|Bid||69.51 x 1000|
|Ask||70.84 x 4000|
|Day's Range||68.81 - 71.45|
|52 Week Range||49.26 - 142.11|
|Beta (5Y Monthly)||0.31|
|PE Ratio (TTM)||56.65|
|Earnings Date||Nov 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||79.25|
Subscribe to Yahoo Finance Plus to view Fair Value for HAELearn more
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock […]
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, November 9, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on November 9, 2021.